AbstractImmunization against the Aβ peptide reverses the pathologic and behavioral manifestations of Alzheimer’s disease in murine models. Since active immunization is associated with an autoimmune meningoencephalitis in a subset of humans, passive transfer of anti-Aβ immunoglobulin is being pursued as a potentially safer alternative. We have identified cases of meningoencephalitis subsequent to peripheral and intracerebral passive immunization of Tg2576 mice. The vasocentric mononuclear infiltrate localized only to brain regions affected by Aβ amyloid deposits suggesting that the inflammatory reaction was Aβ specific. This report indicates that current passive immunization in humans should proceed with careful regard for autoimmune complic...
Immunization against Aβ can reduce amyloid accumulation in vivo and is considered a potential therap...
The neuropathology of Alzheimer's disease(AD) is characterized by the accumulation of amyloid peptid...
Amyloid-beta peptide (Abeta) has a key role in the pathogenesis of Alzheimer disease (AD). Immunizat...
Abstract Background Passive immunization with antibod...
Abstract Background Passive immunization with antibodies directed to Aβ decreases brain Aβ...
Abstract Background Passive immunization with antibodies directed to Aβ decreases brain Aβ/amyloid b...
AbstractAccumulation in brain of the β-amyloid peptide (Aβ) is considered as crucial pathogenic even...
Alzheimer's disease (AD) is a neurodegenerative disorder primarily affecting regions of the brain re...
Active immunization with fibrillar beta-amyloid peptide (AB42) as well as passive transfer of anti-A...
Amyloid-beta peptide (Aβ)-directed active and passive immunization therapeutic strategies reduce bra...
Alzheimer's disease (AD) is the most common form of dementia in the elderly. AD is characterized by ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized pathologi...
BackgroundAlzheimer's disease, a common dementia of the elder, is characterized by accumulation of p...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized pathologi...
Immunization against amyloid-β (Aβ) can reduce amyloid accumulation in vivo and is considered a pote...
Immunization against Aβ can reduce amyloid accumulation in vivo and is considered a potential therap...
The neuropathology of Alzheimer's disease(AD) is characterized by the accumulation of amyloid peptid...
Amyloid-beta peptide (Abeta) has a key role in the pathogenesis of Alzheimer disease (AD). Immunizat...
Abstract Background Passive immunization with antibod...
Abstract Background Passive immunization with antibodies directed to Aβ decreases brain Aβ...
Abstract Background Passive immunization with antibodies directed to Aβ decreases brain Aβ/amyloid b...
AbstractAccumulation in brain of the β-amyloid peptide (Aβ) is considered as crucial pathogenic even...
Alzheimer's disease (AD) is a neurodegenerative disorder primarily affecting regions of the brain re...
Active immunization with fibrillar beta-amyloid peptide (AB42) as well as passive transfer of anti-A...
Amyloid-beta peptide (Aβ)-directed active and passive immunization therapeutic strategies reduce bra...
Alzheimer's disease (AD) is the most common form of dementia in the elderly. AD is characterized by ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized pathologi...
BackgroundAlzheimer's disease, a common dementia of the elder, is characterized by accumulation of p...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized pathologi...
Immunization against amyloid-β (Aβ) can reduce amyloid accumulation in vivo and is considered a pote...
Immunization against Aβ can reduce amyloid accumulation in vivo and is considered a potential therap...
The neuropathology of Alzheimer's disease(AD) is characterized by the accumulation of amyloid peptid...
Amyloid-beta peptide (Abeta) has a key role in the pathogenesis of Alzheimer disease (AD). Immunizat...